Gadobutrol (Gadavist, BAY86-4875)

DRUG2 trials

Sponsors

Bayer, UConn Health

Conditions

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced ImagesMagnetic Resonance Imaging

Phase 1

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

CompletedNCT01544166

BayerMagnetic Resonance Imaging

Start: 2012-05-16End: 2013-11-28Updated: 2020-12-16

Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

RecruitingNCT06846853

UConn HealthContrast Enhanced Images vs. Non-contrast Images, Gadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images

Start: 2025-03-01End: 2025-12-25Target: 10Updated: 2025-04-15